SCHEMBL6986173

SCHEMBL6986173

NC(=O)C(c1ccc(Cl)cc1)c1cccc(O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
HIF1A Q16665 1/20 0.43
KDM4E B2RXH2 1/20 0.43
HTT P42858 2/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HDAC4 P56524 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
TSHR P16473 1/20 0.41
KYNU Q16719 1/20 0.41
PARP1 P09874 1/20 0.41
ADRB1 P08588 1/20 0.40
MIF P14174 1/20 0.40
HTR2A P28223 1/20 0.40
ADRA1A P35348 1/20 0.40
HTR2B P41595 1/20 0.40
MGAM O43451 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4505807 0.83 HTT (0.56) LMNAHTTGAAMAPTSMN1; SMN2
SCHEMBL3739983 0.82 HDAC4 (0.57) LMNAHTTGAAMAPTSMN1; SMN2
SCHEMBL31362087 0.80 MEN1 (0.45) LMNAHIF1AKDM4EMAPTSMN1; SMN2
SCHEMBL18530335 0.75 PARP1 (0.52) LMNAHIF1AKDM4EGAATSHR
SCHEMBL8365159 0.74 PARP1 (0.43) LMNAGAASMN1; SMN2PARP1CNR1
SCHEMBL28038711 0.73 KMT2A (0.54) LMNAGAAHDAC4HDAC7HDAC5
SCHEMBL5843644 0.73 LMNA (0.48) LMNAHIF1AKDM4EGAAHDAC4
SCHEMBL10411665 0.73 ADRB1 (0.49) LMNAHIF1AKDM4EGAATSHR
SCHEMBL443291 0.72 MEN1 (0.47) LMNAHIF1AKDM4EHTTMAPT
SCHEMBL18557600 0.72 KYNU (0.51) LMNAHIF1AKDM4EHDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322617-A1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARMACEUTICALS, INC. (US) 2003-07-02 EP disclosed
WO-2002024653-A1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARMACEUTICALS, INC. (US) 2002-03-28 WO disclosed